NBP NovaBridge Biosciences
Fundamentals / CIK 0001778016 / USDNovaBridge Biosciences reported $260.5M in total assets and a net loss of $46.27M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open NBP in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$94.27M Operating profit
-
Net Income FY 2025-$46.27M GAAP bottom line
-
Diluted EPS FY 2025-$0.21 Split-adjusted
-
Free Cash Flow FY 2025-$20.60M Operating CF less CapEx
-
Cash & ST Investments Dec 31, 2025$210.8M Total debt: $3.07M
Annual revenue and net income
7 fiscal years (2019 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | $632K | -$1.55M | $13.81M | $236.4M | $4.31M |
| Cost of Revenue | -- | -- | -- | $3.95M | $7.29M | -- | -- |
| Gross Profit | -- | -- | -- | -$5.50M | $6.53M | -- | -- |
| Research & Development | $62.91M | $21.77M | $21.45M | $22.55M | $190.3M | $150.9M | $120.7M |
| Total Operating Expenses | $94.27M | $51.43M | $72.65M | $51.53M | -- | -- | -- |
| Operating Income | -$94.27M | -$51.43M | -$72.02M | -$53.08M | -- | -- | -- |
| EBITDA | -$94.20M | -$51.13M | -$71.52M | -$52.88M | -- | -- | -- |
| Interest Income | $7.61M | $7.49M | $9.29M | $4.95M | $3.35M | $3.71M | $4.39M |
| Interest Expense | -- | -- | $102K | $1.0K | $0 | $147K | $430K |
| Income Before Tax | -$88.34M | -$49.70M | -$82.22M | -$141.1M | -$366.4M | $74.04M | -$208.6M |
| Income Tax Expense | $0 | $0 | $0 | $103K | -$495K | $1.87M | -- |
| Net Income | -$46.27M | -$22.23M | -$207.7M | -$371.1M | -$365.9M | $72.17M | -$208.6M |
| Basic EPS | -$0.21 | -$0.12 | -$1.09 | -$1.96 | -$2.09 | $0.54 | -$28.90 |
| Diluted EPS | -$0.21 | -$0.12 | -$1.09 | -$1.96 | -$2.09 | $0.46 | -$28.90 |
| Basic Shares Outstanding | 220.3M | 186.7M | 191.4M | 189.8M | 174.7M | 134.2M | 7.4M |
| Diluted Shares Outstanding | 220.3M | 186.7M | 191.4M | 189.8M | 174.7M | 157.2M | 7.4M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $210.6M | $68.26M | $291.5M | $342.9M | $552.9M | $729.3M | $163.4M |
| Short-Term Investments | $210K | $105.1M | $20.22M | $34.13M | $118.2M | $4.83M | $4.60M |
| Cash & Short-Term Investments | $210.8M | $173.4M | $311.7M | $377.1M | $671.1M | $734.1M | $168.0M |
| Accounts Receivable, Net | -- | -- | -- | $0 | $5.19M | $20.00M | -- |
| Inventory | -- | -- | -- | $0 | $4.27M | -- | -- |
| Total Current Assets | $217.5M | $176.7M | $329.9M | $525.8M | $750.4M | $819.0M | $195.5M |
| Property, Plant & Equipment, Net | $140K | $201K | $1.78M | $8.82M | $7.17M | $3.87M | $4.32M |
| Goodwill | -- | -- | -- | $23.57M | $25.51M | $24.92M | $23.35M |
| Intangible Assets | -- | -- | $16.64M | $17.24M | $18.78M | $18.46M | $21.38M |
| Long-Term Investments | $0 | $30.82M | -- | -- | -- | -- | -- |
| Other Non-Current Assets | $2.81M | $1.36M | $248K | $1.58M | $4.18M | $308K | $2.63M |
| Total Non-Current Assets | $43.00M | $35.99M | $39.01M | $64.84M | $128.6M | $151.7M | $54.05M |
| Total Assets | $260.5M | $212.7M | $368.9M | $590.6M | $878.9M | $970.7M | $249.6M |
| Short-Term Debt | -- | -- | $4.22M | $2.75M | -- | -- | $7.18M |
| Deferred Revenue (Current) | -- | -- | $310K | $1.26M | -- | -- | -- |
| Other Current Liabilities | $9.18M | $106K | $4.94M | -- | -- | -- | -- |
| Total Current Liabilities | $26.89M | $8.45M | $58.14M | $109.9M | $97.92M | $88.30M | $84.53M |
| Deferred Revenue (Non-Current) | -- | -- | $41.15M | $38.84M | $35.15M | -- | -- |
| Other Non-Current Liabilities | $511K | $0 | $106K | $2.46M | $2.34M | $1.38M | -- |
| Total Non-Current Liabilities | $2.69M | $3.07M | $68.19M | $58.81M | $65.53M | $20.00M | $11.44M |
| Total Liabilities | $29.58M | $11.52M | $126.3M | $168.7M | $163.5M | $108.3M | $95.96M |
| Total Debt (incl. Leases) | $3.07M | $3.88M | $10.56M | $10.87M | $17.65M | $2.08M | $9.24M |
| Common Stock | $27K | $19K | $19K | $19K | $20K | $17K | $1.0K |
| Retained Earnings | -$1.33B | -$1.29B | -$1.26B | -$994.9M | -$683.4M | -$310.1M | -$358.3M |
| Accumulated Other Comp. Income | $41.55M | $33.38M | $39.77M | $31.00M | -$29.27M | -$7.78M | $10.07M |
| Total Stockholders' Equity | $230.9M | $201.2M | $242.6M | $417.8M | $715.1M | $862.4M | -$292.3M |
| Total Equity | $230.9M | $201.2M | $242.6M | $417.8M | $715.1M | $862.4M | -$292.3M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $210.6M | $68.26M | $291.5M | $342.9M | $552.9M | $729.3M | $163.4M |
| Short-Term Investments | $210K | $105.1M | $20.22M | $34.13M | $118.2M | $4.83M | $4.60M |
| Cash & Short-Term Investments | $210.8M | $173.4M | $311.7M | $377.1M | $671.1M | $734.1M | $168.0M |
| Accounts Receivable, Net | -- | -- | -- | $0 | $5.19M | $20.00M | -- |
| Inventory | -- | -- | -- | $0 | $4.27M | -- | -- |
| Total Current Assets | $217.5M | $176.7M | $329.9M | $525.8M | $750.4M | $819.0M | $195.5M |
| Property, Plant & Equipment, Net | $140K | $201K | $1.78M | $8.82M | $7.17M | $3.87M | $4.32M |
| Goodwill | -- | -- | -- | $23.57M | $25.51M | $24.92M | $23.35M |
| Intangible Assets | -- | -- | $16.64M | $17.24M | $18.78M | $18.46M | $21.38M |
| Long-Term Investments | $0 | $30.82M | -- | -- | -- | -- | -- |
| Other Non-Current Assets | $2.81M | $1.36M | $248K | $1.58M | $4.18M | $308K | $2.63M |
| Total Non-Current Assets | $43.00M | $35.99M | $39.01M | $64.84M | $128.6M | $151.7M | $54.05M |
| Total Assets | $260.5M | $212.7M | $368.9M | $590.6M | $878.9M | $970.7M | $249.6M |
| Short-Term Debt | -- | -- | $4.22M | $2.75M | -- | -- | $7.18M |
| Deferred Revenue (Current) | -- | -- | $310K | $1.26M | -- | -- | -- |
| Other Current Liabilities | $9.18M | $106K | $4.94M | -- | -- | -- | -- |
| Total Current Liabilities | $26.89M | $8.45M | $58.14M | $109.9M | $97.92M | $88.30M | $84.53M |
| Deferred Revenue (Non-Current) | -- | -- | $41.15M | $38.84M | $35.15M | -- | -- |
| Other Non-Current Liabilities | $511K | $0 | $106K | $2.46M | $2.34M | $1.38M | -- |
| Total Non-Current Liabilities | $2.69M | $3.07M | $68.19M | $58.81M | $65.53M | $20.00M | $11.44M |
| Total Liabilities | $29.58M | $11.52M | $126.3M | $168.7M | $163.5M | $108.3M | $95.96M |
| Total Debt (incl. Leases) | $3.07M | $3.88M | $10.56M | $10.87M | $17.65M | $2.08M | $9.24M |
| Common Stock | $27K | $19K | $19K | $19K | $20K | $17K | $1.0K |
| Retained Earnings | -$1.33B | -$1.29B | -$1.26B | -$994.9M | -$683.4M | -$310.1M | -$358.3M |
| Accumulated Other Comp. Income | $41.55M | $33.38M | $39.77M | $31.00M | -$29.27M | -$7.78M | $10.07M |
| Total Stockholders' Equity | $230.9M | $201.2M | $242.6M | $417.8M | $715.1M | $862.4M | -$292.3M |
| Total Equity | $230.9M | $201.2M | $242.6M | $417.8M | $715.1M | $862.4M | -$292.3M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Net Income | -$88.34M | -$22.23M | -$207.7M | -$371.1M | -$365.9M | $72.17M | -$208.6M |
| Depreciation & Amortization | $68K | $300K | $500K | $200K | $2.28M | $2.19M | $1.41M |
| Stock-Based Compensation | $5.97M | -$1.95M | $10.24M | $13.15M | $95.50M | $75.63M | $52.70M |
| Change in Receivables | -- | -- | -- | -$2.75M | $15.29M | -$20.00M | -- |
| Change in Inventory | -- | -- | -- | $3.95M | -$4.27M | -- | -- |
| Operating Cash Flow | -$20.60M | -$52.67M | -$183.8M | -$159.9M | -$152.7M | $66.45M | -$124.7M |
| Capital Expenditure | -$7.0K | -$48K | -$164K | -$2.09M | -$4.70M | -$1.23M | -$1.76M |
| Free Cash Flow | -$20.60M | -$52.72M | -$184.0M | -$162.0M | -$157.4M | $65.22M | -$126.4M |
| Purchases of Investments | -- | -$51.12M | -$124.7M | -$1.07B | -- | -- | -- |
| Sales & Maturities of Investments | $154.9M | $109.8M | $85.00M | $764.4M | -- | -- | -- |
| Investing Cash Flow | $105.0M | -$136.0M | $14.44M | $66.46M | -$114.1M | -$30.94M | $30.52M |
| Share Repurchases | -- | -$335K | -$8.64M | -$3.01M | $0 | -$5.34M | -- |
| Financing Cash Flow | $57.73M | -$335K | $1.07M | $6.14M | $93.20M | $527.3M | $21.94M |
| Net Change in Cash | $142.4M | -$242.4M | -$164.7M | -$77.30M | -$193.8M | $546.4M | -$70.05M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Gross Margin | -- | -- | -- | -- | 47.3% | -- | -- |
| Operating Margin | -- | -- | -11395.1% | -- | -- | -- | -- |
| Net Profit Margin | -- | -- | -32868.5% | -- | -2648.7% | 30.5% | -4840.1% |
| Return on Equity (ROE) | -20.0% | -11.1% | -85.6% | -88.8% | -51.2% | 8.4% | -- |
| Return on Assets (ROA) | -17.8% | -10.5% | -56.3% | -62.8% | -41.6% | 7.4% | -83.6% |
| Current Ratio | 8.09x | 20.90x | 5.67x | 4.78x | 7.66x | 9.28x | 2.31x |
| Quick Ratio | 7.84x | 20.51x | 5.36x | 4.78x | 7.62x | 8.54x | 1.99x |
| Debt to Equity | 0.01x | 0.02x | 0.04x | 0.03x | 0.02x | 0.00x | -- |
| Revenue Growth (YoY) | -- | -- | -- | -111.2% | -94.2% | +5386.7% | -- |
| Gross Profit Growth (YoY) | -- | -- | -- | -184.3% | -- | -- | -- |
| Net Income Growth (YoY) | -- | -- | -- | -- | -607.0% | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -487.0% | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -329.8% | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -341.3% | -- | -- |
| 5Y Net Income / Share Growth | -139.0% | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.